Biotech VCs

Venture Capital Funding

AstronauTx biotech closes £48m Series A for Alzheimer’s drugs

London-based biotech developing drugs to cure Alzheimer’s, a disease which affects 55m people a year and costs the economy tens of billions

Venture Capital Funding

Venture capital biotech funding increases 35% year on year

Venture capital channels over £2m a day into biotech, accounting for two thirds of all biotech funding


Number of biotechnology companies grows by two thirds over three years

Biotech business population flourishes since 2016 as annual investment reaches £2.2bn in 2018


Roman Abramovich’s Ervington Investments backs biotech company Weedingtech

Weed management business Weedingtech has added to the funding it received in the summer of 2013 by bagging a further £750,000.


‘Lego for DNA’ biotech start-up secures £150,000 of SEIS capital from Mercia

The Seed Enterprise Investment Scheme (SEIS) has allowed biotechnology business Oxford Genetics to net £150,000 of new funding.


Biofortuna secures £1.1 million

Early stage investment firms EV and Catapult Venture Managers have backed Liverpool-based molecular diagnostics company Biofortuna.


Investment veteran airs fears over UK biotech

Sir Christopher Evans may have raised £100 million this year, but he is still worried about the lack of investment in the UK's biotech industry. He spoke to Mark Dunne


Pivotal deal for NVM

Pivotal Laboratories, a Yorkshire-based business that conducts clinical trials for pharmaceutical and biotech firms, has completed a multi-million-pound management buyout with the aid of Northern Venture Managers (NVM).